Tribulova N, Knezl V, Shainberg A, Seki S, Soukup T
Eine aktuelle Pressemitteilung zu Semaglutid berichtet ber eine erste kardiovaskulre Outcomes-Studie mit Teilnehmern, die sowohl eine Adipositas als auch eine vorbestehende atherosklerotische Herz-Kreislauf-Erkrankung hatten (SELECT-Studie, ClinicalTrials.gov NCT NCT03574597)
Fellow mental health clinicians and healthcare providers, you now have access to a suite of free CME lectures on metabolic psychiatry and metabolic health
In very young children, a chest X-ray may be needed to rule out pneumonia
Your exact protocol and dosing format are determined during your medical evaluation
West Virginia residents struggle to afford GLP-1 weight loss drugs after state ends subsidy program A class of drugs known as GLP-1s have been helping people lose weight, but out of pocket costs put them out of reach for many Americans